When.com Web Search

  1. Ads

    related to: neuroendocrine tumor injections nhs

Search results

  1. Results From The WOW.Com Content Network
  2. Lutetium (177Lu) oxodotreotide - Wikipedia

    en.wikipedia.org/wiki/Lutetium_(177Lu)_oxodotreotide

    177 Lu dotatate was approved in the United States for the treatment of SSTR positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs), including foregut, midgut and hindgut neuroendocrine tumors in adults, in January 2018. [3] [6] [7] This was the first time a radiopharmaceutical had been approved for the treatment of GEP-NETs in the ...

  3. Neuroendocrine tumor - Wikipedia

    en.wikipedia.org/wiki/Neuroendocrine_tumor

    Neuroendocrine tumors (NETs) are neoplasms that arise from cells of the endocrine and nervous systems.They most commonly occur in the intestine, where they are often called carcinoid tumors, but they are also found in the pancreas, lung, and the rest of the body.

  4. Peptide receptor radionuclide therapy - Wikipedia

    en.wikipedia.org/wiki/Peptide_receptor...

    [1] [11] [12] [13] When it comes to comparing these two PRRT, Y-labeled and Lu-labeled PRRTs, it appears that Y-labeled is more effective for larger tumors, while Lu-labeled is better for smaller and primary tumors. The lack of ɤ-emission with Y-labeled PPRTs is also an important difference between Lu peptides and Y peptide.

  5. Small intestine neuroendocrine tumor - Wikipedia

    en.wikipedia.org/wiki/Small_intestine...

    The tumor typically produces serotonin, Tachykinin peptides and other substances, which cause flushing, tachycardia, diarrhea and in some cases fibrosis of the heart valves. [citation needed] There are often several small and highly fibrotic tumors present in the intestine. The tumors often spread to the mesenteries and the liver. [citation needed]

  6. Gastrinoma - Wikipedia

    en.wikipedia.org/wiki/Gastrinoma

    Gastrinoma is the second most common functional pancreatic neuroendocrine tumor (pNET), with a yearly incidence of approximately 0.5 to 21.5 cases per a million of people worldwide. [5] Gastrinomas are located predominantly in the duodenum (70%) and pancreas (25%). [ 20 ]

  7. Carcinoid syndrome - Wikipedia

    en.wikipedia.org/wiki/Carcinoid_syndrome

    Carcinoid syndrome is a paraneoplastic syndrome comprising the signs and symptoms that occur secondary to neuroendocrine tumors (formerly known as carcinoid tumors). [1] The syndrome is caused by neuroendocrine tumors most often found in the gut releasing biologically active substances into the blood causing symptoms such as flushing and diarrhea, and less frequently, heart failure, vomiting ...